QR-Code

Integrated Safety Analysis on Skin Cancers among Patients with Psoriasis Receiving Ixekizumab in Clinical Trials

Abstract Introduction Limited data exist on skin cancer risk in patients with psoriasis using biologics. Here, we report treatment-emergent adverse events (TEAEs) of skin cancer in patients treated with ixekizumab from psoriasis clinical trials. Methods Integrated safety databases from 17 clinical t...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Saxon D. Smith, Alexandros Stratigos, Matthias Augustin, Jose Manuel Carrascosa, Susanne Grond, Elisabeth Riedl, Wen Xu, Himanshu Patel, Mark Lebwohl
Format: Artigo
Sprache:Inglês
Veröffentlicht: Adis, Springer Healthcare 2023-06-01
Schriftenreihe:Dermatology and Therapy
Schlagworte:
Ixekizumab
Long-term
Malignancy
Melanoma
Non-melanoma skin cancer
Psoriasis
Online-Zugang:https://doi.org/10.1007/s13555-023-00966-4
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge